Related Experiment Video
Updated: Jun 13, 2025

13:34
Assessment of Memory Function in Pilocarpine-induced Epileptic Mice
Published on: June 4, 2020
8.3K
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment
Ifrah Zawar1, Mark Quigg1,2, Emily L Johnson3
1Comprehensive Epilepsy Program, Department of Neurology, University of Virginia, Charlottesville.
JAMA Neurology
|April 14, 2025
Summary
Late-onset epilepsy (LOE) risk increases in people with cognitive decline. Factors like APOE4 allele, early dementia onset, stroke, and Parkinson disease are associated with developing LOE.
Area of Science:
- Neurology
- Geriatrics
- Cognitive Science
Background:
- Late-onset epilepsy (LOE) risk increases significantly after age 60, especially in individuals with cognitive decline (PWCD).
- Epilepsy is linked to poorer cognitive and mortality outcomes in PWCD, highlighting the need for early detection.
- Identifying individuals at risk for LOE can enable timely screening and intervention.
Purpose of the Study:
- To investigate the factors associated with the development of late-onset epilepsy (LOE) in people with cognitive decline (PWCD).
Main Methods:
- A longitudinal, multicenter study analyzed data from 14,685 PWCD across 39 US Alzheimer's Disease Research Centers.
- Participants were aged 60 years or older, without prior epilepsy, and followed over time.
- Multivariable Cox regression assessed associations between various factors (genetics, comorbidities, cognition, lifestyle) and LOE development.
Main Results:
- Of 14,685 participants, 221 (1.5%) developed LOE.
- Associated risk factors for LOE included the APOE4 allele, dementia onset before age 60, worse cognition, Alzheimer disease dementia, stroke/transient ischemic attack (TIA), and Parkinson disease.
- Sensitivity analysis confirmed these associations with an alternative LOE definition (onset after 65).
Conclusions:
- The APOE4 allele, early dementia onset, Alzheimer disease dementia, cognitive impairment, stroke/TIA, and Parkinson disease are significant risk factors for LOE in PWCD.
- PWCD exhibiting these risk factors may benefit from routine electroencephalogram screening for early LOE detection.
- Early identification and management of LOE in at-risk PWCD can potentially improve cognitive and mortality outcomes.
Related Concept Videos
Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107
Arteries of the Lower Limbs
181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
Alzheimer's Disease: Overview
452
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
452
Seizures: Classification
309
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
309
Cognitive Development During Adulthood
68
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
68
Antiepileptic Drugs: GABAergic Pathway Potentiators
343
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
343

